Compare Stocks

Date Range: 

 Avalon GloboCareATIFLightbridgeWilhelmina InternationalPharma-Bio Serv
SymbolNASDAQ:AVCONASDAQ:ATIFNASDAQ:LTBRNASDAQ:WHLMOTCMKTS:PBSV
Price Information
Current Price$0.92$0.93$4.72$5.08$1.27
52 Week RangeN/AN/AN/AN/AN/A
MarketRank™
Overall Score0.80.50.60.81.3
Analysis Score0.00.00.00.00.0
Community Score2.52.32.32.32.3
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.01.70.8
Earnings & Valuation Score0.00.00.60.03.1
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$77.89 million$43.10 million$30.44 million$24.24 million$29.76 million
Beta0.57-0.893.330.170.35
Average Volume455,5253,676,882311,074647,40818,508
Sales & Book Value
Annual Revenue$1.55 million$690,000.00N/A$75.50 million$19.51 million
Price / Sales50.2563.46N/A0.351.53
CashflowN/AN/AN/A$1.64 per share$0.09 per share
Price / CashN/AN/AN/A3.0913.92
Book Value$0.06 per share$0.74 per share$6.10 per share$4.13 per share$0.88 per share
Price / Book15.381.26N/A1.231.44
Profitability
Net Income$-18,070,000.00$-14,880,000.00$-10,590,000.00$-4,790,000.00$2.09 million
EPSN/AN/AN/AN/A$0.09
Trailing P/E Ratio0.000.00N/AN/A12.70
Forward P/E Ratio∞∞∞∞7.94
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,071.90%N/AN/A-19.22%11.16%
Return on Equity (ROE)-314.81%N/A-49.93%-28.69%11.08%
Return on Assets (ROA)-134.45%N/A-47.63%-16.34%8.55%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.62%N/AN/A0.12%0.05%
Current Ratio0.88%0.67%9.68%1.04%7.62%
Quick Ratio0.88%0.67%9.68%1.04%7.62%
Ownership Information
Institutional Ownership Percentage3.24%0.55%3.26%4.69%N/A
Insider Ownership Percentage73.40%N/A7.30%65.80%51.40%
Miscellaneous
Employees619770220
Shares Outstanding84.41 million47.02 million6.58 million5.16 million23.43 million
Next Earnings Date5/13/2021 (Estimated)N/A5/11/2021 (Confirmed)5/13/2021 (Estimated)6/21/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average of $1.35Pharma-Bio Serv (OTCMKTS:PBSV) Shares Cross Below Two Hundred Day Moving Average of $1.35
americanbankingnews.com - May 5 at 2:56 AM
Pharma-Bio Serv (OTCMKTS:PBSV) Stock Crosses Above 50 Day Moving Average of $1.30Pharma-Bio Serv (OTCMKTS:PBSV) Stock Crosses Above 50 Day Moving Average of $1.30
americanbankingnews.com - April 24 at 2:30 AM
Short Interest in Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Drops By 50.0%Short Interest in Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Drops By 50.0%
americanbankingnews.com - April 15 at 4:29 PM
Pharma-Bio Serv announces $4.5M in revenues for quarter ended Jan. 31Pharma-Bio Serv announces $4.5M in revenues for quarter ended Jan. 31
newsismybusiness.com - March 18 at 8:38 AM
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2021Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2021
finance.yahoo.com - March 17 at 10:13 PM
Prometheus Bio’s IPO raises $190M for inflammatory bowel disease R&DPrometheus Bio’s IPO raises $190M for inflammatory bowel disease R&D
medcitynews.com - March 13 at 1:58 AM
Global Bio Decontamination Market Size , Segmentation, Share, Forecast, Analysis, Industry Report to 2019-2025Global Bio Decontamination Market Size , Segmentation, Share, Forecast, Analysis, Industry Report to 2019-2025
marketwatch.com - March 11 at 7:50 PM
Pharma-Bio Serv Announces Results for the Year Ended October 31, 2020Pharma-Bio Serv Announces Results for the Year Ended October 31, 2020
finance.yahoo.com - February 1 at 9:34 AM
Pharma-Bio Serv Inc.: Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special DividendPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Dividend
finanznachrichten.de - January 5 at 8:10 PM
Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special DividendPharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Dividend
finance.yahoo.com - January 5 at 8:10 PM
PBSV: Pharma-Bio Serv – Looking Ahead to 2021-2022PBSV: Pharma-Bio Serv – Looking Ahead to 2021-2022
finance.yahoo.com - December 29 at 7:04 PM
Pharma-Bio Serv Inc.Pharma-Bio Serv Inc.
barrons.com - December 2 at 9:37 PM
Tetra Bio-Pharma releases positive results for ARDS-003 in animal studies for treating inflammatory lung injuryTetra Bio-Pharma releases positive results for ARDS-003 in animal studies for treating inflammatory lung injury
proactiveinvestors.com - October 21 at 9:07 AM
Bio-Pharma Market SWOT Analysis by Key Players- Johnson & Johnson, Sanofi, Amgen, AbbVieBio-Pharma Market SWOT Analysis by Key Players- Johnson & Johnson, Sanofi, Amgen, AbbVie
sbwire.com - October 19 at 6:59 PM
Alpha Bronze LLC: Tetra Bio-Pharma to Present at Alpha Bronze Virtual Town HallAlpha Bronze LLC: Tetra Bio-Pharma to Present at Alpha Bronze Virtual Town Hall
finanznachrichten.de - October 6 at 1:46 PM
BridgeBio Pharma and Eidos Therapeutics Announce Merger AgreementBridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
markets.businessinsider.com - October 5 at 7:15 AM
Acer Therapeutics to Present at the Virtual BIO Investor Forum DigitalAcer Therapeutics to Present at the Virtual BIO Investor Forum Digital
markets.businessinsider.com - October 1 at 1:06 PM
EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).
markets.businessinsider.com - September 30 at 2:19 PM
Bio Pharma Logistics Market 2020 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026Bio Pharma Logistics Market 2020 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026
marketwatch.com - September 29 at 6:25 PM
Ajinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis TherapeuticAjinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic
prnewswire.com - September 29 at 8:24 AM
Contract Biomanufacturing Services Global Market - Forecast to 2028Contract Biomanufacturing Services Global Market - Forecast to 2028
markets.businessinsider.com - September 28 at 9:01 AM
Aside from Covid-19, what lies ahead for British pharma firms?Aside from Covid-19, what lies ahead for British pharma firms?
thisismoney.co.uk - September 23 at 9:08 AM
Erytech Pharma S.A.: ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with CowenErytech Pharma S.A.: ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen
finanznachrichten.de - September 21 at 8:19 PM
PBSV: Trump promises to revitalize pharmaceuticals in Puerto RicoPBSV: Trump promises to revitalize pharmaceuticals in Puerto Rico
finance.yahoo.com - September 21 at 3:18 PM
BioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy IndustryBioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
prnewswire.com - September 21 at 10:18 AM
DateCompanyBrokerageAction
(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]arketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.